glp-1 anti-obesity signaling pathway in obesity pathogenesis. The GLP-1 Therapy Part 1: Setting

Diabetes Obes Metab (2011) 13:110513

Jan M, Anwar-ul-Haq M, Shah AN, Yousaf M, Iqbal J, Li X et al (2019) Modulation in growth, gas exchange, and antioxidant activities of salt-stressed rice ( Oryza sativa L.) genotypes by zinc fertilization

Saxenda is a prescription weight-management medicine containing liraglutide 6 mg/ml, a GLP-1 (glucagon-like peptide-1) receptor agonist

Table 3 also showed the results of the previous cycle and the subsequent cycle for 362 controls, without any adjuvant medication

Older adults who tend to take more medications are at greater risk of drug interactions

Systemic side effects are rare but include transient nausea (510% of patients, typically within the first hour post-injection) and allergic reactions to methylcobalamin or preservatives in compounded formulations